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efritis  intersticial  aguda  por  ibup
o the Editor,
cute tubulointerstitial nephritis (ATIN) leads to acute kidney
amage; it has a low incidence in the paediatric population1,2
nd is present in up to 15% of renal biopsies performed in
dults for acute kidney damage.3 Currently, the most com-
on  cause of ATIN is drugs. Other causes include infection,
mmunological disease (such as systemic lupus erythemato-
us or Sjögren’s syndrome), and sometimes the cause is
nknown.4 Several groups of drugs have been identiﬁed
s ethiological agents: antibiotics and non-steroidal anti-
nﬂammatory drugs (NSAIDs), which are extensively used in
outine clinical practice, are among the most frequently impli-
ated in ATIN.5
We  present 3 cases of paediatric patients with non-oliguric
cute kidney damage, seen in our department between 2008
nd 2010, with a working diagnosis of NSAID-induced (ibupro-
en) ATIN.None of the children had a past history of kidney disease or
ther past medical history of relevance, and all had had blood
ests in the previous months with normal creatinine levels and
he estimated glomerular ﬁltration rate according to the origi-
al Schwartz formula6 were normal. On physical examination,
here were no signs of dehydration, blood pressures were
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normal for the patients’ age, sex, and height, and there was
no oedema. There were no features of obstructive uropathy
or evidence of glomerulopathy (C3 and C4 complement study,
immunoglobulins, and ANA were normal). The 3 patients
had received ibuprofen before developing kidney damage. The
patients’ clinical characteristics and laboratory results are pre-
sented in Table 1.
On admission, ibuprofen treatment was stopped in
patients 1 and 3. Patient 2, who was referred from another
hospital, had stopped the medication 2 days before admission
to our department. Once a diagnosis of ATIN was suspected,
treatment was started with intravenous methylprednisolone
boluses (15 mg/kg/day for 3 consecutive days, accounting for
250–500 mg  iv/day of methylprednisolone) followed by oral
prednisolone (starting dose 1 mg/kg/day) at a reducing dose,
which was then stopped at 8 weeks. None of the patients had
adverse effects attributable to steroids. Urea  and creatinine
returned to normal levels during the ﬁrst week in all 3 casesue de Pablos A, Morales San-José MD, Rodríguez Sanchez de la
trica. Nefrologia. 2016;36:69–71.
(Fig. 1). Urinary biochemistry and sediment returned to normal
within 6 months.
Drug-induced ATIN is the result of a cell-mediated hyper-
sensitivity reaction to a drug. It occurs independently of the
route of administration (intravenous, intramuscular, oral, or
rectal)4 and the duration of treatment.7 Patients who  have had
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Table 1 – Clinical details and investigations.
Case number 1 2 3
Age (years), gender 4, male 12, female 12, female
Weight (kg) 17 38 37
Reason for taking NSAIDs Urethroplasty Headache Appendicectomy
Duration of NSAID (days), dose 5
5 mg/kg/8 h
3
10  mg/kg/8 h
4
10  mg/kg/8 h
Symptoms Vomiting, abdominal pain,
weakness
Macroscopic haematuria
and fever
Nausea,  vomiting, loss of
appetite
Baseline serum creatinine (mg/dL) 0.32 0.50 0.51
Baseline urea (mg/dL) 21 23 20
Maximum creatinine (mg/dL) 2.7 3 1.5
Maximum urea (mg/dL) 140 182 90
Urinalysis Some isolated red cells and
white cells. No eosinophils
100+  red cells/ﬁeld and
granular casts. No
eosinophils
1–2 leucocytes and 5–10 red
cells/ﬁeld. No eosinophils
Proteinuria with P:Cr ratio Proteinuria with P:Cr ratio P:Cr ratio 0.3 mg/mg. Osmo
of 1.3 mg/mg and tubular
component. Osmo
262 mOsm/kg
Renal ultrasound Kidneys mildly enlarged.
Cortical hyperechogenicity
and increased
corticomedullary
differentiation
drug-induced ATIN should avoid further exposure to the drug,
as recurrence is possible.
The clinical manifestations are variable, and the severity of
symptoms varies from asymptomatic urinary abnormalities
to acute kidney damage (oliguric or non-oliguric), which may
require extra-renal replacement therapy. The classic manifes-
tations (fever, rash, and arthralgia) are present in only 10%
of cases5; the most common manifestations are non-speciﬁc
symptoms such as abdominal pain, vomiting, anorexia, weak-
ness, or fever.
Urinalysis may show proteinuria (generally in the non-
nephrotic range and predominantly tubular), haematuria,
leukocytes, granular hyaline casts, and eosinophils (which are
less common in the NSAID-induced ATIN). There may also be
other clinical manifestations of tubular injury abnormalities
depending on the segment affected (such as glycosuria, bicar-
bonaturia, tubular acidosis, inability to concentrate urine). A
normal sediment does not exclude ATIN.
Ultrasound of the urinary system may show enlarged kid-
neys and increased echogenicity in the cortex.8 The gold
standard for diagnosis is renal biopsy, which shows inﬂamma-
tory cell inﬁltration of the renal interstitium (T lymphocytes,
monocytes, macrophages plasma cells, eosinophils) along
with local oedema and, occasionally, ﬁbrosis. There may be
tubulitis, and the vessels and glomeruli are usually normal.9
The ﬁrst step in treatment is to stop the drug responsible
and provide adequate supportive treatment for the degree of
established kidney damage. Use of corticosteroids as part of
the treatment has been debated for years; however, recent
publications support their use because they have been demon-
strated to improve the prognosis of renal function recovery.
Therefore, starting treatment early is the main prognostic
marker.10,111.9 mg/mg and tubular
component. Osmo
453 mOsm/kg
303 mOsm/kg
Diffuse parenchymal
hyperechogenicity of both
kidneys with loss of
corticomedullary
differentiation
Diffuse cortical
hyperechogenicity
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Fig. 1 – Changes over time in urea and creatinine levels.Renal biopsy is the investigation of choice to conﬁrm the
diagnosis. However, none of our patients underwent biopsy,
because they progressed well clinically and biochemically
once the responsible agent was stopped (immediately after the
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iagnosis was suspected) and corticosteroid treatment was
tarted. The corticosteroid protocol used, by González et al,
s described above.10 The 3 patients showed a rapid response
o treatment, and the outcome has been excellent. However,
enal biopsy should be considered in cases that are slow to
esolve or in case of diagnostic uncertainty.
It is important to explore the past drug history in patients
ith acute renal failure without previous renal disease or
igns of dehydration, and in whom ultrasound of the urinary
ract has ruled out obstructive causes. The ﬁrst step in the
reatment of ATIN is to stop the causative drug and provide
dequate supportive therapy. Early administration of cortico-
teroids once a diagnosis is suspected is associated with early
esolution of renal failure.
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